Governance Amgen Inc.

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-10 pm EST			5-day change	1st Jan Change
364.65 ^USD	-2.97%		+7.70%	+11.41%

Feb. 10	Mizuho Raises Price Target on Amgen to $295 From $280, Keeps Outperform Rating	MT
Feb. 10	Daiwa Securities Adjusts Price Target on Amgen to $410 From $370, Maintains Outperform Rating	MT

Executive Committee: Amgen Inc.

Manager

Positions heldSince

Robert Bradway

63 year

Chief Executive Officer	2012-04-30
President	2010-04-30

Scott Skellenger

Chief Tech/Sci/R&D Officer

2022-09-30

Howard Y. Chang

Chief Tech/Sci/R&D Officer

2024-12-15

Paul Burton

57 year

Chief Tech/Sci/R&D Officer

2023-05-31

James Bradner

53 year

Chief Tech/Sci/R&D Officer

2023-12-17

Matthew Busch

52 year

Comptroller/Controller/Auditor

2023-08-13

Derek Miller

53 year

Human Resources Officer

2004-08-31

Mark J. Taisey

General Counsel

2013-12-31

Nancy Grygiel

58 year

Compliance Officer

2015-12-31

Peter Griffith

67 year

Director of Finance/CFO

2019-12-31

Esteban Santos

59 year

Chief Operating Officer

2016-07-24

Jonathan Graham

65 year

General Counsel	2015-07-12
Corporate Secretary	2015-07-12

David Reese

63 year

Chief Tech/Sci/R&D Officer

2018-07-25

Composition of the Board of Directors: Amgen Inc.

Director

CommitteesSince

Robert Bradway

63 year

Executive Committee Chair	2012-12-31
Compensation Committee	2016-10-13
Governance Committee Chair

Robert Eckert

71 year

Compensation Committee	2021-03-25
HR Committee	2021-03-25
Governance Committee Chair	2021-03-25
Nominating Committee Chair	2021-03-25
Executive Committee	2011-12-31
Governance Committee	2020-03-19
Nominating Committee	2020-03-19
Compensation Committee Chair

Greg Garland

68 year

Executive Committee
Compensation Committee	2013-10-15
Governance Committee Chair
Nominating Committee Chair
Audit Committee	2025-11-02
Finance Committee	2025-11-02

Charles Holley

69 year

Executive Committee	2017-02-02
Governance Committee
Nominating Committee	2017-02-02
Audit Committee Chair	2020-03-31
Audit Committee	2019-10-03
Finance Committee	2019-10-03

Wanda Austin

71 year

Compensation Committee	2017-10-23
Governance Committee Chair	2016-11-30
Nominating Committee Chair	2016-11-30
Audit Committee
Finance Committee

Amy Miles

59 year

Governance Committee	2025-01-14
Audit Committee Chair
Finance Committee Chair	2020-03-31
Audit Committee	2025-01-14
Nominating Committee	2020-07-22

Ellen Kullman

70 year

Governance Committee Chair	2023-05-07
Nominating Committee Chair	2023-05-07
Governance Committee	2016-12-20
Nominating Committee	2016-12-20
Compensation Committee	2016-12-20

Omar Ishrak

71 year

Audit Committee	2023-07-31
Compensation Committee	2021-07-29
Governance Committee	2023-07-31
Nominating Committee	2023-07-31

Mary Klotman

72 year

Governance Committee	2024-05-30
Nominating Committee	2022-11-10
Compensation Committee	2022-11-10

Tyler Jacks

65 year

Finance Committee	2015-02-23
Compensation Committee

Michael Drake

75 year

Governance Committee	2022-08-02
Nominating Committee	2022-08-02

Brian Druker

70 year

Compensation Committee

2018-05-22

Latest Appointments: Amgen Inc.

Feb. 03	Pyxis Oncology, Inc. Announces Chief Executive Officer Changes, Effective February 3, 2026	CI
Jan. 28	Vera Therapeutics Announces Appointment of Matt Skelton as Chief Commercial Officer, Effective January 28, 2026	CI
Jan. 26	Janux Therapeutics, Inc. Announces Chief Medical Officer Changes	CI
Jan. 22	MBX Biosciences, Inc. Announces Board and Committee Changes	CI
Jan. 13	Aligos Therapeutics, Inc. Appoints James Hassard as Executive Vice President and Chief Commercial Officer, Effective January 13, 2026	CI
Jan. 12	BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer	MT
Jan. 12	BioMarin Pharmaceutical Inc. Appoints Arpit Davé as Executive Vice President and Chief Digital and Information Officer	CI

More news

Former Officers and Directors: Amgen Inc.

Insider

Positions held

SinceUntil

Frank Herringer

Director/Board Member	2004-04-30	2019-05-21
Independent Dir/Board Member	2011-04-21	2019-05-21

David Baltimore

Director/Board Member	1996-12-31	2018-05-21
Independent Dir/Board Member	2011-04-21	2018-05-21

Frank J. Biondi

Director/Board Member	2001-12-31	2017-05-18
Independent Dir/Board Member	2011-04-21	2017-05-18

Judith C. Pelham

Director/Board Member	1995-04-30	2017-05-18
Independent Dir/Board Member	2011-04-21	2017-05-18

Rolf K. Hoffmann

Corporate Officer/Principal

2004-10-31

2016-06-30

Vance D. Coffman

Director/Board Member	2007-10-01	2015-12-31
Independent Dir/Board Member	2011-04-21	2015-12-31

Willard Dere

Chief Tech/Sci/R&D Officer	2007-05-31	2014-09-30
Corporate Officer/Principal	2007-05-31	2007-05-31

Joseph P. Miletich

Chief Tech/Sci/R&D Officer

2002-03-31

2014-06-30

Gilbert Omenn

Director/Board Member	1986-12-31	2014-05-14
Independent Dir/Board Member	2011-04-21	2014-05-14

Leonard Schaeffer

Director/Board Member	2004-02-29	2013-07-07
Independent Dir/Board Member	2011-04-21	2013-07-07

J. Reason

Director/Board Member	2000-12-31	2013-05-21
Independent Dir/Board Member	2011-04-21	2013-05-21

Fabrizio Bonanni

Chief Operating Officer

1999-03-31

2012-12-31

David Beier

Public Communications Contact	2011-04-18	2012-10-07
General Counsel	2003-11-30	2012-10-07
Corporate Officer/Principal	2012-10-07	2012-12-31

Kevin Sharer

Chief Executive Officer	1999-12-31	2012-04-30
Chairman	1992-09-30	2012-12-30
President	1992-09-30	1999-12-31

Roger Perlmutter

Chief Tech/Sci/R&D Officer

2000-12-31

2012-02-11

Roy Baynes

Corporate Officer/Principal

2002-07-31

2011-12-31

Frederick Gluck

Director/Board Member	1998-01-31	2011-09-30
Independent Dir/Board Member	2011-04-21	2011-09-30

Lisa Guttman

Corporate Officer/Principal

1999-12-31

2007-09-30

Richard Nanula

Director of Finance/CFO

2001-07-31

2007-04-09

Donald B. Rice

Director/Board Member

2000-09-30

2007-01-16

Lisa A. Evrén

Treasurer

2001-12-31

2006-12-31

Hassan A. Dayem

Chief Tech/Sci/R&D Officer

2002-04-30

2006-09-19

Timothy Martin

Comptroller/Controller/Auditor	2003-07-31	2006-04-30
Director of Finance/CFO	2003-07-31	2006-04-30

David Parkinson

Corporate Officer/Principal

2003-04-30

2006-02-28

Keith L. Klein

General Counsel

1990-12-31

2005-12-31

Edward V. Fritzky

Director/Board Member

2002-06-30

2005-04-30

Charles R. Bradley

Corporate Officer/Principal

1999-12-31

2004-12-31

Michael Narachi

Corporate Officer/Principal

1984-06-30

2002-12-31

Thomas James Flanagan

Chief Tech/Sci/R&D Officer

2004-05-31

Steve Lazarus

Director/Board Member

1987-04-30

2004-05-12

Patricia Cary Sueltz

Director/Board Member	2002-01-07	2004-04-30
Independent Dir/Board Member	2002-01-07	2004-04-30

David J. Scott

General Counsel	2004-02-29	-
Corporate Secretary	2004-02-29	-

Joseph J. Tsiakals

Corporate Officer/Principal

1999-12-31

2003-12-31

Bradley J. Maroni

Corporate Officer/Principal

1997-12-31

2003-12-31

Martha E. Vincent

Chief Tech/Sci/R&D Officer

1994-12-31

2003-12-31

Kevin B. Young

Corporate Officer/Principal

2000-12-31

2003-12-31

Wen-Tse Tseng

Corporate Officer/Principal

1998-09-09

2003-09-09

Diane M. Palumbo

Human Resources Officer

1991-05-31

2003-06-30

Carl LeBel

Corporate Officer/Principal

1992-12-31

David Hallal

Sales & Marketing

1991-12-31

2002-07-31

Nicholas Lydon

Corporate Officer/Principal

2000-11-30

2002-01-01

Robin D. Campbell

Corporate Officer/Principal

1988-12-31

2001-12-31

Brian M. McNamee

Human Resources Officer	2001-05-31	2013-11-06
Corporate Officer/Principal	2013-11-06	-

Matthew Moyle

Corporate Officer/Principal

1994-12-31

2000-12-31

Gordon Binder

Chief Executive Officer

1981-12-31

1999-12-31

Henry Wu

Corporate Officer/Principal

1998-12-31

Gisela Schwab

Chief Tech/Sci/R&D Officer

1991-12-31

Denny Lanfear

Corporate Officer/Principal

1985-12-31

1998-12-31

Jerry D. Choate

Director/Board Member	1998-07-31	-
Independent Dir/Board Member	2011-04-21	-

Julia Eastland

Comptroller/Controller/Auditor

1996-02-29

1998-03-31

Danute M. Bankaitis-Davis

Chief Tech/Sci/R&D Officer

1991-12-31

1997-12-31

Rosemary Mazanet

Chief Tech/Sci/R&D Officer

1992-12-31

1997-12-31

Kathleen M. Wiltsey

Sales & Marketing

1983-12-31

1997-12-31

Margaret E. Valeur-Jensen

Corporate Officer/Principal

1990-12-31

1997-12-31

Gregory Stea

Sales & Marketing

1988-04-30

1996-12-31

Peter García

Corporate Officer/Principal

1989-12-31

Richard Yeh

Corporate Officer/Principal

1995-09-30

Mark Moon

Corporate Officer/Principal

1988-12-31

1995-01-01

Lowell Sears

Director of Finance/CFO

1985-12-31

1993-12-31

Alan B. Forsythe

Corporate Officer/Principal

1990-12-31

G. Kirk Raab

Director/Board Member

1980-12-31

1984-12-31

Bertrand C. Liang

Corporate Officer/Principal

Joshua Disbrow

Corporate Officer/Principal

Alexander Lopez

Corporate Officer/Principal

Elaine Richardson

Corporate Officer/Principal

Howard J. Lewin

Corporate Officer/Principal

Edward H. Shin

Corporate Officer/Principal

David Polk

Public Communications Contact

Alec Green

Corporate Officer/Principal

Jeffrey D. Webster

Corporate Officer/Principal

M. Patricia Beckmann

Corporate Officer/Principal

Nancy Stuart

Corporate Officer/Principal

Ralph Niven

Corporate Officer/Principal

Kathleen Stafford

Treasurer

Steve Bandler

Corporate Officer/Principal

Sanjay Kanungo

Corporate Officer/Principal

Steven R. Wiley

Corporate Officer/Principal

James H. Chamberlain

Corporate Officer/Principal

John Shutter

Public Communications Contact

Luc Marengère

Corporate Officer/Principal

Ernest Allen

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	25
Female	6

Of which Executive Committee

Male	12
Female	1

Of which Directors

Male	10
Female	2

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Yes

Conforme à la finance Islamique

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.4% of net sales.

Employees

28,000

Sector

Pharmaceuticals

Calendar

Feb. 12 -

More about the company